Background Extracorporeal photopheresis (ECP) is the main non‐pharmacological
approach accompanying systemic medical treatments in steroid‐resistant acute or chronic …

Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory therapy,
has previously demonstrated promising results in treating chronic graft-versus-host disease …

Graft-versus-Host Disease (GVHD) is the primary cause of late morbidity and mortality after
allogeneic stem cell transplantation (SCT). In chronic GVHD (cGVHD), often multiple organ …

Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only
curative option for many patients diagnosed with hematological malignancies. A major …

We enrolled 25 patients with extensive, steroid-refractory chronic graft-versus-host disease
(cGVHD) in a prospective trial evaluating the efficacy of extracorporeal photophoresis (ECP) …

Photopheresis (extracorporeal photochemotherapy, ECP) is a new type of
photochemotherapy used for the treatment of oncological and autoimmune diseases …

Results Compared to the control group and the stable/progressive disease (SD/PD) patients,
individuals with complete/partial remission have higher overall survival and lower transplant …

Background Extracorporeal photopheresis (ECP) is recommended as a second-or later-line
therapy for chronic GvHD (cGvHD). Benefits include reasonable response with avoidance of …

Late immune dysregulation following allogeneic hematopoietic cell transplantation (HCT) is
known as chronic graft-versus-host disease (GVHD), which is a major cause of mortality and …

Graft-versus-host disease (GVHD) is a significant cause of morbidity and mortality among
patients undergoing hematopoietic stem cell transplantation (HSCT)[1, 2]. Patients with …